Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $49.3 million as of January 29, 2026. Its market cap has increased by 293.43% in one year.

Market Cap

49.30M

Enterprise Value

50.14M

Revenue

41.92M

Ranking

n/a

PE Ratio

16.41

Stock Price

$1.78

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 49.30M, a decrease of -77.79%. That is a compound annual growth rate of -5.28%.

Market Cap History

Date	Market Cap	% Change
Jan 28, 2026	49.30M	804.90%
Dec 31, 2025	5.45M	-54.11%
Dec 31, 2024	11.87M	152.98%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Global Cord Blood	127.22M
China New Energy Group Co.	74.89M
Bioqual	34.44M
Aspira Women's Health	19.48M
Longduoduo Company	17.81M
Psychemedics	11.02M
Hypha Labs	5.44M
Stella Diagnostics	4.67M

Market Cap Rankings